Form 4: Hims & Hers Chief Legal Officer Sells Over 3,200 Shares Under Pre-Arranged Trading Plan

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 3,233 shares of Class A Common Stock for approximately $180,600 as part of a Rule 10b5-1 trading plan.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), disposed of 3,233 shares of Class A Common Stock.
• The transaction occurred on May 27, 2025, at a price of $55.87 per share.
• The total value of the shares sold is approximately $180,600.71.
• Following this transaction, Ms. Boughton directly beneficially owns 153,194 shares of Class A Common Stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can be seen as negative, the fact that it's part of a pre-arranged 10b5-1 plan mitigates any negative implications, making it a routine, expected event for personal liquidity or portfolio diversification.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information and is a routine liquidity event.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the insider's direct ownership stake in the company.

Risks

• While routine, insider sales can sometimes be perceived negatively by the market, potentially signaling a lack of confidence, though this is mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

This is a routine insider transaction for Hims & Hers Health, Inc., a telehealth platform. Such transactions are common across all industries for executive compensation and personal financial planning, especially when executed under a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders: The sale slightly reduces the Chief Legal Officer's direct ownership, which could be interpreted as a minor negative signal, though the 10b5-1 plan mitigates this.
• Employees: No direct impact on employees is indicated.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Sale, Soleil Boughton, Chief Legal Officer, 10b5-1 Plan, Equity Transaction